Press releaseGlobe Newswire
Cytek Biosciences
CTKB · NASDAQ
$5.34+$0.09 (+1.71%)TodayMarket closed ·
Prev close $5.25
Latest news
- Press releaseGlobe Newswire
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
- Press releaseGlobe Newswire
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
- Press releaseGlobe Newswire
Cytek Biosciences to Participate in Upcoming Investor Conferences
- Press releaseGlobe Newswire
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
- Press releaseGlobe Newswire
Cytek Biosciences Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
- NewsAvi Kapoor
Ryanair Posts Weak Q1 Results, Joins HDFC Bank And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Press releaseGlobe Newswire
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
- Press releaseGlobe Newswire
Cytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conference
- Press releasePRNewswire
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
- NewsAvi Kapoor
Concrete Pumping Holdings Reports Blowout Q2 Results, Joins ServiceTitan and Other Big Stocks Moving Higher in Friday's Pre-Market Session
- Press releaseGlobe Newswire
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
- NewsAvi Kapoor
Braze Posts Mixed Q1 Results, Joins Sidus Space, Everpure And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
Cytek Biosciences Reports First Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
- Press releaseGlobe Newswire
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
- News
Earnings Breakdown: Cytek Biosciences Q4
- News
Cytek Biosciences Q4 EPS $(0.34) Misses $(0.02) Estimate, Sales $62.141M Beat $57.187M Estimate
- Press releaseGlobe Newswire
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
- News
Earnings Scheduled For February 26, 2026
- Press releaseGlobe Newswire
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference
- Press releaseGlobe Newswire
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
- News
Cytek Sees $62M Q4 Revenue Vs $56.99M Est, Forecasts About $201M in Full-Year 2025 Sales Vs $196.71M Est
- Press releaseGlobe Newswire
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results
- Press releaseGlobe Newswire
TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026
- Press releaseGlobe Newswire
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
- Press releaseGlobe Newswire
Cytek Biosciences to Participate in Upcoming Investor Conferences
- Press releaseGlobe Newswire
Cytek Biosciences Reports Third Quarter 2025 Financial Results
- Press releaseGlobe Newswire
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
- Press releaseGlobe Newswire
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
- Press releaseGlobe Newswire
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
- News
Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock
- News
Earnings Scheduled For May 8, 2025
- NewsAvi Kapoor
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
- NewsAvi Kapoor
Crude Oil Gains 1%; Chicago PMI Falls In December
- Press releaseGlobe Newswire
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
- Press releaseGlobe Newswire
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.